Geographic Atrophy

"Geographic Atrophy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A form of MACULAR DEGENERATION also known as dry macular degeneration marked by occurrence of a well-defined progressive lesion or atrophy in the central part of the RETINA called the MACULA LUTEA. It is distinguishable from WET MACULAR DEGENERATION in that the latter involves neovascular exudates.

Descriptor ID	D057092
MeSH Number(s)	C11.768.585.439.122
Concept/Terms	Geographic Atrophy Geographic Atrophy Atrophies, Geographic Atrophy, Geographic Geographic Atrophies Dry Macular Degeneration Degeneration, Dry Macular Degenerations, Dry Macular Dry Macular Degenerations Macular Degeneration, Dry Macular Degenerations, Dry

Below are MeSH descriptors whose meaning is more general than "Geographic Atrophy".

Diseases [C]
Eye Diseases [C11]
Retinal Diseases [C11.768]
Retinal Degeneration [C11.768.585]
Macular Degeneration [C11.768.585.439]
Geographic Atrophy [C11.768.585.439.122]

Below are MeSH descriptors whose meaning is related to "Geographic Atrophy".

Below are MeSH descriptors whose meaning is more specific than "Geographic Atrophy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Geographic Atrophy" by people in this website by year, and whether "Geographic Atrophy" was a major or minor topic of these publications.

Bar chart showing 15 publications over 10 distinct years, with a maximum of 2 publications in 2011 and 2016 and 2017 and 2021 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2010	1	0	1
2011	1	1	2
2013	1	0	1
2015	1	0	1
2016	0	2	2
2017	2	0	2
2019	1	0	1
2020	1	0	1
2021	2	0	2
2024	2	0	2

Below are the most recent publications written about "Geographic Atrophy" by people in Profiles.

Sharma A, Wu L, Bloom S, Stanga P, Abreu N, Eichenbaum D, Regillo C, Guymer R, Madan KH, Rezaei KA. RWC Update: Removal of Subretinal Band Without Retinotomy; Geographic Atrophy: How Do You Select Appropriate Patients for Anti-Complement Therapy?; Shaken Baby Syndrome. Ophthalmic Surg Lasers Imaging Retina. 2024 Jun; 55(6):305-308.

View in: PubMed
Boyer D, Hu A, Warrow D, Xavier S, Gonzalez V, Lad E, Rosen RB, Do D, Schneiderman T, Ho A, Munk MR, Jaffe G, Tedford SE, Croissant CL, Walker M, R?ckert R, Tedford CE. LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System. Retina. 2024 Mar 01; 44(3):487-497.

View in: PubMed
Mahmoudzadeh R, Salabati M, Khan MA, Garg SJ, Hsu J. Manual Versus Semi-Automated Measurement of Geographic Atrophy Area in Eyes With Age-Related Macular Degeneration. Transl Vis Sci Technol. 2021 08 02; 10(9):33.

View in: PubMed
Mahmoudzadeh R, Hinkle JW, Hsu J, Garg SJ. Emerging treatments for geographic atrophy in age-related macular degeneration. Curr Opin Ophthalmol. 2021 May 01; 32(3):294-300.

View in: PubMed
Ammar MJ, Hsu J, Chiang A, Ho AC, Regillo CD. Age-related macular degeneration therapy: a review. Curr Opin Ophthalmol. 2020 May; 31(3):215-221.

View in: PubMed
Heier JS, Ho AC, Samuel MA, Chang T, Riemann CD, Kitchens JW, Slakter JS, Leiderman YI, Spencer R, Williams GA, Hickson-Curran SB, Keane M, Baldassarre JS. Safety and Efficacy of Subretinally Administered Palucorcel for Geographic Atrophy of Age-Related Macular Degeneration: Phase 2b Study. Ophthalmol Retina. 2020 04; 4(4):384-393.

View in: PubMed
Yaspan BL, Williams DF, Holz FG, Regillo CD, Li Z, Dressen A, van Lookeren Campagne M, Le KN, Graham RR, Beres T, Bhangale TR, Honigberg LA, Smith A, Henry EC, Ho C, Strauss EC. Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration. Sci Transl Med. 2017 06 21; 9(395).

View in: PubMed
Ho AC, Chang TS, Samuel M, Williamson P, Willenbucher RF, Malone T. Experience With a Subretinal Cell-based Therapy in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration. Am J Ophthalmol. 2017 Jul; 179:67-80.

View in: PubMed
Schlanitz FG, Baumann B, Kundi M, Sacu S, Baratsits M, Scheschy U, Shahlaee A, Mitterm?ller TJ, Montuoro A, Roberts P, Pircher M, Hitzenberger CK, Schmidt-Erfurth U. Drusen volume development over time and its relevance to the course of age-related macular degeneration. Br J Ophthalmol. 2017 Feb; 101(2):198-203.

View in: PubMed
Ildefonso CJ, Jaime H, Brown EE, Iwata RL, Ahmed CM, Massengill MT, Biswal MR, Boye SE, Hauswirth WW, Ash JD, Li Q, Lewin AS. Targeting the Nrf2 Signaling Pathway in the Retina With a Gene-Delivered Secretable and Cell-Penetrating Peptide. Invest Ophthalmol Vis Sci. 2016 Feb; 57(2):372-86.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement